Man Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Man Group’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,344,632	Closed	-$25.4M	–	1984
2019 Q3	$25.4M	Buy	+1,344,632	New	+$15.4M	0.09%	258
2018 Q4	–	Sell	-513,491	Closed	-$8.55M	–	2230
2018 Q3	$8.55M	Buy	513,491 +359,602	+234%	+$6.5M	0.03%	707
2018 Q2	$2.43M	Sell	153,889 -202,825	-57%	-$3.08M	0.01%	1284
2018 Q1	$4.53M	Buy	+356,714	New	+$5.16M	0.02%	908

Man Group's ALDR Position: Q4 2019 in Review

Man Group sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 1,344,632 shares — an estimated $25.4M sold.

Man Group first reported a position in ALDR in Q1 2018 and held it in 4 quarters. The position peaked at $25.4M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Man Group reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Man Group sold 1,344,632 Alder Biopharmaceuticals shares in Q4 2019, an estimated $25.4M.
Man Group first reported a position in Alder Biopharmaceuticals in Q1 2018 and held it in 4 quarters.
Man Group's Alder Biopharmaceuticals position peaked at $25.4M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Man Group's 13F filing for Q4 2019, filed 18 Feb 2020.